scorecardresearch
Business Today
Subscribe
Immersives UPSTART G20 Summit Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Bal Pharma Ltd

Feedback
Bal Pharma Ltd

Bal Pharma Ltd (BALPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 42,616
Sep 14, 2023 15:42 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹95.40
₹0.60 (0.63%)
₹94.85 Low
Today’s Performance
₹96.5 High
₹63.35 Low
52 Week’s Performance
₹106.5 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 0.63%
  • 1 Week -4.93%
  • 1 Month 0.74%
  • 3 Months 8.97%
  • 6 Months 34.37%
  • 1 Year -3.59%
  • 3 Years 30.07%
  • 5 Years -1.32%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.22
  • 52-Week Low (₹) 63.35
  • 52-Week High (₹) 106.50
  • Price-to-Book (X)* 2.35
  • Dividend Yield (%) 1.05
  • Price-to-Earnings (P/E) (X)* 63.31
  • Earnings Per Share (₹) 1.51
  • Sector Price Earning (X)* 33.20
  • Market Cap (₹ Cr.)* 149.68
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 39:53 Historic India-Middle East-Europe Corridor Puts China On Notice
THUMB 5:05 Delhi Tops In Terms Of Electric Buses After Arvind Kejriwal Govt Introduces 400 New Buses
thumb 4:42 The India-Middle East-Europe Corridor: A Counter To China's Belt & Road Initiative
THUMB 4:04 Putin Praises Modi’s ‘Make In India’, Cites Example To Russian Auto Industry
THUMB 9:44 Tata Motors' Electrifying Future: In Conversation With Shailesh Chandra On EV Expansion
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Mar 22, 2023 PURCHASE
Bal Pharma Limited ,AJAY PARAKH
  • Qty 100000
  • Average Price ₹70.00
Mar 22, 2023 Sell
Bal Pharma Limited ,VEENA PARAKH
  • Qty 102000
  • Average Price ₹70.00
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Bal Pharma Ltd share price previously?
Bal Pharma Ltd share price was up by 0.63% from the previous closing price of ₹94.80.
Who are peers of Bal Pharma Ltd?
The peers of Bal Pharma Ltd are Dr Reddys Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Aurobindo Pharma Ltd, Glenmark Pharmaceuticals Ltd, Divis Laboratories Ltd, Alkem Laboratories Ltd, Gland Pharma Ltd, Cipla Ltd, Lupin Ltd, Biocon Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, Glaxosmithkline Pharmaceuticals Ltd, Syngene International Ltd.
Who is/are the promoter/promoters of Bal Pharma Ltd?
The promotor/promotors of Bal Pharma Ltd are Shailesh Siroya, C V Srinivas, Himesh Virupakshaya, H S Venkatesh, Nicola Neeladri, Jatish Sheth, Kotian Chittananda Damodar, Abdul Basith.
What has been 52-week high of Bal Pharma Ltd stocks?
The highest price of Bal Pharma Ltd stock is ₹106.50 in the last 52-week.
What is the share price of Bal Pharma Ltd (BALPHARMA) today on NSE?
As on Sep 14, 2023, Bal Pharma Ltd (BALPHARMA)’s share price on NSE is Rs 95.4
What is the market cap of Bal Pharma Ltd (BALPHARMA?)
The current market capitalisation of Bal Pharma Ltd (BALPHARMA) is 149.68 crores
What is Bal Pharma Ltd Share symbol?
The symbol of Bal Pharma Ltd is BALPHARMA.
What is the PE ratio of Bal Pharma Ltd (BALPHARMA)?
The current PE ratio of Bal Pharma Ltd (BALPHARMA) is 63.31.
What is the PB ratio of Bal Pharma Ltd (BALPHARMA)?
The current PB ratio of Bal Pharma Ltd (BALPHARMA) is 2.35.
Today’s High & Low share prices of Bal Pharma Ltd (BALPHARMA) on NSE?
Today, the share price of Bal Pharma Ltd (BALPHARMA) on NSE touched a high of Rs 96.5 and a low of Rs 94.85
What price did Bal Pharma Ltd (BALPHARMA) shares open on the NSE today?
On NSE, the share price of Bal Pharma Ltd (BALPHARMA) opened at Rs 96.2
What is the 52-week high of Bal Pharma Ltd (BALPHARMA)?
The 52-week high price of Bal Pharma Ltd (BALPHARMA) is Rs 106.5
What is the 52-week low of Bal Pharma Ltd (BALPHARMA) ?
The 52-week low price of Bal Pharma Ltd (BALPHARMA) is Rs 63.35

ABOUT BAL PHARMA

Bal Pharma Ltd, incorporated in the year 1987, has its registered office in 21 & 22 Bommasandra Indl Area, Hosur Road, Bangalore, Karnataka, 560092. The main industry in which Bal Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Bal Pharma Ltd is/are NSVM & Associates. In the main management, is chairman and Abdul Basith is the company secretary for Bal Pharma Ltd.

  • SS Shailesh Siroya Managing Director
  • CVS C V Srinivas Independent Director
  • HV Himesh Virupakshaya Executive Director
  • HSV H S Venkatesh Independent Director
  • NN Nicola Neeladri Independent Director
  • JS Jatish Sheth Independent Director
  • KCD Kotian Chittananda Damodar Whole-time Director
  • AB Abdul Basith Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.